Msh Capital Advisors LLC Bristol Myers Squibb CO Transaction History
Msh Capital Advisors LLC
- $373 Billion
- Q3 2025
A detailed history of Msh Capital Advisors LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Msh Capital Advisors LLC holds 8,034 shares of BMY stock, worth $376,071. This represents 0.1% of its overall portfolio holdings.
Number of Shares
8,034
Previous 7,811
2.85%
Holding current value
$376,071
Previous $362 Million
0.21%
% of portfolio
0.1%
Previous 0.1%
Shares
16 transactions
Others Institutions Holding BMY
# of Institutions
2,682Shares Held
1.58BCall Options Held
28MPut Options Held
28.4M-
Vanguard Group Inc Valley Forge, PA196MShares$9.17 Billion0.14% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.43 Billion0.15% of portfolio
-
State Street Corp Boston, MA96.6MShares$4.52 Billion0.16% of portfolio
-
Jpmorgan Chase & CO New York, NY86.2MShares$4.03 Billion0.26% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA73MShares$3.42 Billion0.55% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $99.5B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...